Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So they wont promote the company or dc-vax in the US? But they can in UK.
Merger would explain the silence and dilution. For those saying buyout, they would want to promote stock and elevate SP I would think. Also. senior mngmt owns millions of shares, you would think they also would want to promote and raise SP unless they have an endgame plan that nets them more. just my 2 cents
I was thinking the same thing. I asked before if dilution counted as volume and was told yes. So how does adding 2 million shares not equal 2 million volume?
so one day after good news, they issue 2 million more shares? No one else is bothered by this? Its almost as if they want to keep SP down.
Ive been a fan of alphastocks for a years. They post on this board also, but havent seen them in a while. That being said, they are in no way associated with the apes. They do not command them, they do not control them. Last time this was tried was after may fiasco. At that time someone posted the apes do not get involved in penny stocks. I dont know if this is true since i have nothing to do with them and am not on reddit. Yes, I would love to see them get involved and see a short squeeze. But I am not counting on them, much as I havent counted on Biden fast tracking approval because of his son, or MHRA fast tracking approval because of the kings cancer, or a whistleblower stepping forward in lawsuit, or musk buying out the company or a dozen more hail marys posted through the years. Approval, marketing, partnerships, thats where I am placing my faith.
Does Les know about this? Since he has appeared on a certain radio show a few times recently.
So the nature article is a fluff piece? ok, got it. This clown is done for the and going to work in the garden. Enjoy your day.
Using this logic, they will remain silent also after submitting to FDA, or only market in the UK?
I have not seen a stirring of the apes. Someone on the board tried to get them involved after the May incident years ago. Then someone else said they dont get involved in OTC stocks. So I wouldnt count on them. But if they can help the share price reach 1000, I'll buy some of their art
I guess this is why they fired their PR team. Why spend the money on something you arent going to use.
"Yesterday I was talking with a retired Dr. friend about all the cautions that must be included in commercials for virtually all drugs. His point was that in a trial, if a patient gets a headache, the only way not to say it may be a side effect of taking the drug is to run perhaps millions of dollars worth of trials to prove it doesn't cause headaches. It's easier and cheaper to just say it may be a side effect. I would much prefer a simple statement that Drs. prescribing a drug should review side effects, and not list everything that was seen during a trial, but the regulators don't see it as I do."
Gary, I hate to say this, but a lot of times you state the obvious. everyone knows about the disclaimers and why they are there.
Great news yesterday and SP goes up 2 cents. Someone is keeping the lid on this and its not MMs. Any day now they will submit to FDA, then the narrative will be yet again, we dont want to piss off an agency so we will remain silent. Its BS.
silence must be a strategy for a bigger end game. the notion they dont want to give ammo to fudsters is also BS. How can mentioning the Nature article be used in any way shape or form for FUD?
I am going to fall back on the old thinking that everyone is lying and no one knows anything concrete, myself included.
why would Les go back on a radio show that has done nothing to help the company yet? He is not a good speaker. His appearance must be by design or is this company so out of it they will continue repeating their mistakes over and over.
Why havent they used the publicity from the lawsuit to make people aware of dc vax? oh wait, they must not want to PO judge. God forbid they promote themselves in any way. At least the weekend is approaching which means another few days closer to approval.
I dont see how a PR acknowledging the article is unprofessional. Just the opposite, i'm sure the publisher would love more exposure.
Its possible, anything is possible. To me it just looks like she has a plan to merge with her other company and then form partnerships. In the long run, probably more profitable than a buyout. In 2028, I believe, nwbo will have sole authority over keytruda/dc-vax combo. The silence, building up manufacturing, the renewal classification of her other company(also a key combo partner), does not point to a buyout to me, at least not of NWBO. Now a buyout of a new combined company, manufacturing in place, approval in place, patents in place, that would be a hefty price tag. Either way, we will have a clearer idea sometime this year.
Why cant they at least acknowledge the nature article? Point interested parties on their website in that direction. Congratulate Nature on their coverage? etc
I dont know if they have a link to Nature article or Jama paper on their website, but why wouldnt they? For a company that wants to supposedly increase its marketability, one PR a month really isnt cutting it. Great nature article, fantastic results, 2 cent increase in SP.
Makes sense from sellers point of view, but not buyers. It also doesnt cover the question of PR silence. If you wanted the most for your company, you would not be in silent mode all the time. Look at the latest news, the nature article. Not a peep from the company. Seems like they are content SP is low.
Why would a company wait until after approval for B/O ? Common business sense says they would buy before approval and get the SP boost upon approval. Unless LP wants the SP boost for herself/nwbo, then another boost from merger, putting them in uplist position. From there its probably partnerships since approval and uplisting would increase value of company 10fold. The numbers from the study are amazing. but also, they have been avail for a while now so you would think a B/O move would have allready been made. Any good offer would have had to go to shareholders and made public, which suggests to me there have been no good offers. Again, just trying to think logically.
Small sample in study, yes, but the numbers are so good, it cant be ignored.
Something that bothers me and doesn't make sense..(unless).The nature journal article is just a peer reviewed summary of the combo trial. That would mean results of the trial are allready well known by certain partys and have been for a while.. Why havent the results been trumpeted around the world, especially by those who financed the study? The article took months to complete and publish. Right now the only logical conclusion I can come up with is no buyout or it would have allready occurred and the published results would have benefitted the B/O company. So I have to think they will merge with LPs other company (sorry, not exactly sure of name ) after approval. Merge, uplist, and go it alone with the new company having multiple partnerships. This would put the new company in the catbirds seat since their patents are approved for many years to come, while patents such as keytruda are coming to a close. The new companys position will only get stronger through time. I am concerned about the age of NWBOs board, but possibly the new company would hire a younger board, send the older ones off with a nice stock package, and move the new company into the future with dc vax becoming SOC for multiple illnesses. Approval, ASM, Asco, partnerships, and merger announcement would be the firestorm of PRs possibly that we were once promised.
The old excuses for no B/O yet dont make sense. The main one being shareholders would not approve takeover of a company with unproven product, yet how many times have we seen a company getting taken over in phase 1 or getting taken over before approval?
Either LPs price is too high or she has another plan. Getting manufacturing up to speed, submitting to MHRA, delay in ASM, new hires(not in NWBO), and change of status for other company would all be part of that plan. But just my opinion trying to look at it logically.
Im still not sure how they prove a monetary value on damages.. MMs will have their own expert witnesses to counter.
Thank you. Would that explain more the day to day volume we've seen the past few years more than mm's mucking with SP? According to the captain, # of shares goes up by about a million every week, while daily volume does the same. You would expect SP manipulation would take much more volume. Or is it mainly the ask that's affecting SP? If short sellers were trying to scoop up shares, wouldnt that account for much more volume since they supposedly sold billions? Not trying to create fud, just trying to get it straight in my head. Watched margin call again last night, good movie.
Stupid stock question, if stock share is added, dilution, does it count as volume on the day?
plus mothers day
I would hope they are currently working their tails off getting ready for next submissions.
no, we are encouraging and supporting people who own stock and have contributed significantly to this board with their expertise for years,
Cannonball? Goliath? Once approval, I expect them to concentrate on next approval, getting treatment to those who need it, getting the word out, partnerships, and sales. This isn't art of war. Get approval, then concentrate on next approval, naked shorts and shortsellers should be in rear view window. We are weeks away from approval. I hope not to hear anymore delays such as they need proofreaders to go over FDA submission. This is time to ramp up the machinery, not fooling around with shortsellers. I dont want a chessplayer right now, I want someone who gets this to market.
Not denying it, but where is PR to let shareholders of NWBO know or potential shareholders? At least they have a good website, which show combo trials. How does the market know the relationship between the 2 companys?
Whatever happened to if the company didnt say it, its not true?
I disagree, its not the bureaucrats who haven't issued an ASM in over a year. The regulators have also granted many patents in many countries, its mngmt that has decided to keep that silent. I see a lot of posts on here about LL giving speeches at various conferences. As a member of NWBO's board, I think those are noteworthy events. Its not bureaucrats forcing NWBO to not promote these events. It wasnt bureaucrats who who forced NWBO to to remain silent when JAMA was published. Bureaucrats had no part in which radio show DI appeared on and the lack of promoting those appearances. Sorry to see Germancol go. He has valid points an many feel the same frustration although selling now would be too much of a loss for me. Now to go to my first tai chi course and enjoy the day. Approval will happen when it happens.
Price drop is unsettling, but application for approval has been submitted and its allready being used in compassionate care cases for years. makes no sense.
Possibly, but LP has her price and it would have to be major collusion among mult BPs.. Just trying to make sense of it. If one BP were behind keeping price low, wouldnt they be afraid some competition would jump in and scoop up shares? There definitely is price manipulation going on, but all the reasons posted dont really make sense if you think about it. At .50 a share, all remaining shares should have been scooped up by BPs , especially merck. The daily average volume does not point to major buying interest. Unless HFs are keeping price low to counter lawsuit argument that price should be much higher. But again, no volume means no SP improvement.
ummmm, responding to a pump post is not creating fear, uncertainty, or doubt, just keeping it real
The old "reverse split" BS rearing its ugly fud head every 2 months. Desperation FUD since every science argument has been countered
I understand grabbing shares to cover naked shorts before buyout, but not keeping price down "for" a buyout.
and tote bags are new design, ...just stop allready
"Linda P mentioned that any action will only be taken after MHRA approval"
I dont recall her saying this. She did say she is open to B/O if price is right.
I can see B/O upon approval, but whats the reasoning for keeping SP low by mm's? SP is in 40's, if they dont get shares to cover now at this price, they never will. We all know SP takes off after approval, so why are mm's dropping by a few pennies every week? Makes no sense. They are not trying to bankrupt the company, not by dropping it pennies.
why would they be keeping price down for a buyout? Makes more sense to grab every share they can get their hands on. But I agree, they are keeping price depressed.
And yet they give a PR. refreshing to see...
"Break out! Maybe close near 52"
what ticker are you watching?
"I feel like NWBO has passed the stage of spreading influence through academic presentation." Hell yes!!
With respect Gary, "By ASCO we'll either have UK approval, or we won't." What the hell does that mean? Thats like saying tomorrow we will have approval or we wont, next week we will have approval or we wont, next month we will have approval or we wont, and so on. The booth and presentation always get attention, so what? It got attention 2 years ago, last year and in all likelihood next year.
As for the UK cannot review 1.5 million pages so fast, they knew enough about dcvax to allow compassionate use. They must have a head start about the science.
" depending on the acceptance date it could fall during ASCO." There you go trying to say NWBO is somehow using ASCO in their timing. Or the UK gives a rats fart about ASCO timing. It doesnt.
My question is LP stated we would get a flood of PRs 3 years ago. So what would have been in those PRs? TLD results, those came and went. Journal article, again, that came and went. Regulatory submittal? That has also came and gone, 3 years after she made the statement. So again, what would NWBO have been PRing? Only thing that fits is partnerships or combo trials. We havent officially heard a peep about either.
These tweets are great, but why doesnt NWBO PR any patents or progress? Unless they want to keep SP low or have deal ready to go. Question, why should NWBO PR these patent approvals? Answer, Im sure investors would like to know , or possible future investors. Patent approval in multiple countries, yet crickets from PR dept. Only through this site do I know about them.
please, stop with the ASCO booth size, location, sponsorship level, which hall they are presenting, who's presenting...etc. Everything depends on MHRA approval right now and no one can predict the timeline. ASCO is great, but not part of any timeline for news.